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Single nucleotide polymorphism arrays
a b s t r a c t
The domestic dog offers a unique opportunity to explore the genetic basis of disease, morphology and
behaviour. Humans share many diseases with our canine companions, making dogs an ideal model
organism for comparative disease genetics. Using newly developed resources, genome-wide association
studies in dog breeds are proving to be exceptionally powerful. Towards this aim, veterinarians and
geneticists from 12 European countries are collaborating to collect and analyse the DNA from large
cohorts of dogs suffering from a range of carefully defined diseases of relevance to human health. This
project, named LUPA, has already delivered considerable results. The consortium has collaborated to
develop a new high density single nucleotide polymorphism (SNP) array. Mutations for four monogenic
diseases have been identified and the information has been utilised to find mutations in human patients.
Several complex diseases have been mapped and fine mapping is underway. These findings should ulti-
mately lead to a better understanding of the molecular mechanisms underlying complex diseases in both
humans and their best friend.
! 2011 Elsevier Ltd. All rights reserved.
Introduction
Purebred dogs have been strongly selected for specific morpho-
logical, physiological and behavioural traits. The level of diversity
observed between dog breeds is unique amongst mammalian spe-
cies and many specific features are inherited in very close limits
within a breed (Parker and Ostrander, 2005). This was largely
achieved by the extensive use of founder dogs expressing the de-
sired traits, which inadvertently also increased the frequency of
the undesirable genes carried by those founders (Asher et al.,
2009; Chase et al., 2009). Recessive as well as dominant defects
with incomplete penetrance or late-onset and complex diseases
are numerous in dogs. Breeding practices have raised concerns
about the health status and well being of purebred dogs (Higgins
and Nicholas, 2008), urging the search for solutions.
Inherited canine disorders include structural or metabolic de-
fects, cardiovascular or neurological diseases, inflammatory disor-
ders with immune system failures and cancers. All these conditions
are equally common in humans and the clinical signs in dogs often
mimic human diseases closely (Tsai et al., 2007). As a result of the
relatively low effective population size within many dog breeds
(compared with humans), the within-breed genetic architecture
is predicted to be simplified and to involve larger gene effects
(since these are less effectively counter-selected in smaller popula-
tions), which are likely to be easier to detect (Sutter et al., 2004;
Karlsson et al., 2007).
Susceptibility genes identified in the dog will not only lead to
diagnostic tools for breeders, but will give novel insights in disease
pathogenesis and hence therapeutic opportunities, as well as to
generate hypotheses to investigate the genetic susceptibility of
similar diseases in humans. The latter is greatly aided by the fact
that dogs and humans share roughly the same gene repertoire
(Lindblad-Toh et al., 2005; Derrien et al., 2009).
Anticipating these opportunities, the dog was the fourth mam-
mal for which a high quality genome sequence was published. Con-
comitantly, a large number of single nucleotide polymorphism
(SNPs; >2 million) were discovered and the architecture of the
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dog genome was largely deciphered (Lindblad-Toh et al., 2005).
Linkage disequilibrium (LD) was shown to extend over much long-
er distances within breeds (as a result of the founder effects
accompanying breed formation), hence drastically reducing the
number of markers needed for genome-wide association studies
(GWAS) compared to humans. However, across breeds, LD was
shown to decay more than one breed (Sutter et al., 2004; Lind-
blad-Toh et al., 2005; Karlsson and Lindblad-Toh, 2008).
LUPA: A European initiative
To enhance the use of the dog as an effective model to study
common complex diseases in human, a consortium of canine
geneticists and clinicians representing 12 countries was formed
and has been funded since 2008 by the European Commission
(EC). The project is named LUPA, after the female wolf which
fed the twins Romulus and Remus, the founders of Roma, to
highlight how humans may benefit from genetic studies per-
formed on their best friend. The 22 collaborating veterinary fac-
ulties and research centres have collected large dog cohorts for
more than 20 carefully defined diseases of relevance to human
health.
LUPA targets five partially overlapping disease categories: can-
cers, cardiovascular disorders, inflammatory disorders, neurologi-
cal disorders and monogenic disorders. Mammary tumours,
melanomas, soft tissue sarcomas and mast cell tumours are the
cancers ‘under the microscope’. Among cardiovascular disorders,
myxomatous mitral valve disease, as well as dilated cardiomyopa-
thy, are currently being explored in several large breeds. A large
study on the genetic basis of common physiological cardiovascular
parameters in healthy dogs from 10 different breeds is a novel and
promising approach to look for genetic variants underlying the var-
iability of blood pressure, cardiac morphology, levels of hormones
and metabolites. Among inflammatory disorders, the project is
tackling different forms of diabetes (mainly dioestrus/gestational
diabetes and autoimmune insulin deficiency diabetes), atopic der-
matitis, thyroiditis and resistance to leishmaniasis. Neurological
diseases include epilepsies in a range of breeds, as well as some
behavioural disorders.
Finally, the LUPA programme includes the study of several de-
fects assumed to be monogenic, which should rapidly lead to the
discovery of causative mutations. It is expected that this will dem-
onstrate the effectiveness of the dog model, provide diagnostic
tests for the elimination of certain defects in the afflicted breeds
and possible assist in resolving ‘orphan’ genetic diseases in
humans.
The collection of cohorts is based on rigorous clinical character-
isation using standardised protocols shared by the clinical teams
involved in the study. For complex disorders, simulations demon-
strated that 100–200 cases with the same number of healthy dogs
should provide adequate power to detect loci conferring a 3–5-fold
increased risk (Lindblad-Toh et al., 2005). DNA from cohorts reach-
ing the required size are sent to one centralised, high-throughput
SNP genotyping facility (Centre National de Genotypage, CNG,
Paris) to ensure homogeneous genotypes. The initial 50 K Affyme-
trix array was replaced in 2009 by the now preferred 172 K array
developed in collaboration with Illumina (A. Vaysse personal
communication).
SNP genotypes collected as part of the LUPA project are
stored in a central database, where they can be accessed by all
collaborators on each specific disease project. GWAS are per-
formed using standard software packages (Plink, Eigenstrat, Gen-
Abel) (Price et al., 2006; Aulchenko et al., 2007; Purcell et al.,
2007) with the optional help of a dedicated statistical genetics
platform.
Generation of a high density canine SNP array
The generation of a novel high density canine SNP array ranks
amongst the major early achievements of the LUPA project. Geno-
mic regions that were underrepresented in the previous SNP col-
lection (Lindblad-Toh et al., 2005), including the X chromosome,
were captured out of multibreed DNA pools and resequenced (A.
Vaysse personal communication). A selection of existing and newly
discovered SNPs was included in a set of 172 K SNPs for the design
of the new Illumina high-density array. The resulting SNP collec-
tion provides more uniform and dense coverage (average distance
13 kb between adjacent SNPs). The array performs remarkably well
with regards to call rate, reproducibility and Mendelian consis-
tency (A. Vaysse personal communication).
Monogenic disorders
Other early successes of LUPA include the elucidation of the
molecular basis of four monogenic diseases.
Primary ciliary dyskinesis
Primary ciliary dyskinesis (PCD) is a respiratory disease segregat-
ing in Old English sheep dogs, amongst other breeds. PCD is a heter-
ogeneous genetic disease resulting from defects in the structure
and/or motility of cilia. The analysis of five affected and 15 healthy
dogs identified a 15 Mb segment on chromosome 34 for which all
affected dogs shared autozygosity. The analysis of six candidate
genes, selected with information from ciliome databases from the
151 genes in the interval, led to the identification of a disrupting
mutation in CCDC39, a gene not previously implicated in PCD.
We studied the integrity of the human orthologue in unresolved
human PCD cases with similar ultrastructural defects in cilia. Alto-
gether, 15 different loss-of-function mutations were found,
explaining half of the examined cases, or approximately 8% of all
‘orphan’ human PCD cases (Merveille et al., 2011). The prevalence
of this disease appears to be high in European Old English sheep
dogs (A.C. Merveille personal communication), but the diagnostic
test that has been developed should be effective to control the dis-
ease if applied thoughtfully.
Ichthyosis
Following a similar approach, the gene causing ichthyosis in
Golden retrievers was found using 20 cases and 20 controls. The
disease is characterised by mild to severe abnormal desquamation
across the whole body. A 2 Mb haplotype on canine chromosome
12 was identified, for which all affected dogs shared homozygosity.
It contained 80 genes, of which three were good candidates. A dis-
ruptive mutation in one of these was shown to be perfectly associ-
ated with the disease, yet never found in any other breed, including
other retrievers.
A canine genetic test has been developed, with the submission
of an international patent. Sequencing the human orthologue in 10
unrelated unresolved cases revealed two different mutations in
two families with lamellar ichthyosis (C. André, personal commu-
nication). The gene, which had not previously been associated with
any dermatological condition, was shown to play an important role
in the cutaneous barrier function.
Neuronal ceroid lipofuscinosis
A disease similar to a neuronal ceroid lipofuscinosis (NCL),
which segregated in a pedigree of American Staffordshire terriers,
was fine-mapped using the 172 K array (Abitbol et al., 2010). In hu-
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mans, NCLs represent a heterogeneous group of genetic neurode-
generative diseases due to storage of intermediate products of bio-
chemical pathways in lysosomes of primarily neurones. The
aetiology of adult forms remains to be established. American Staf-
fordshire terriers suffer from a late onset form of ataxia starting be-
tween 3 and 5 years of age and characterised by a cerebellar
abiotrophy. Histopathological analysis revealed marked loss of
Purkinje cells, with intracellular accumulation of autofluorescent
storage material, a hallmark of NCL. The disease segregates as an
autosomal recessive trait.
Through combined linkage and association analysis using
approximately 300 microsatellites on 60 cases and 60 controls,
the NCL locus was mapped to chromosome 9. Ten control and 12
NCL dogs were genotyped afterwards with the 172 K Illumina ar-
ray to identify additional informative markers. A 1039 kb critical
region was defined that spanned nine protein-coding genes. A
breed-specific non-synonymous substitution in exon 2 of the aryl-
sulphatase G (ARSG) gene was detected in two copies in all affected
dogs and in one copy in healthy carriers. Functional assays demon-
strated that the resulting mutation of a highly-conserved amino
acid leads to a 75% decrease in the enzymatic activity of the ARSG
protein. The ARSG gene, not yet involved in human NCLs, is pres-
ently being investigated as a candidate in human NCL patients.
Channelopathies
LUPA partners identified a mutation in a non-ion channel gene
causing juvenile epilepsy in the Lagotto Romagnolo breed (Jokinen
et al., 2007; Seppälä et al., 2011). Focal seizures in affected dogs oc-
cur at 5–9 weeks of age and resolve spontaneously by 13 weeks of
age. This pattern is reminiscent of common human childhood epi-
lepsies with remission and the identified gene is currently being
screened in cohorts of human patients. In addition to being the first
gene for idiopathic epilepsy found in the dog, this study identified
a novel pathway causing epilepsy when perturbed and provides a
useful large animal model to study the molecular mechanisms
leading to common remitting epilepsies in the developing brain
(Seppälä et al., 2011).
Complex diseases
Using SNP genotypes acquired with the novel 172 K array on
larger cohorts, significant genome-wide associations have already
been obtained for several complex disorders.
Dilated cardiomyopathy
Dilated cardiomyopathy is a condition observed both in humans
and several large dog breeds. LUPA is studying this disease in four
breeds: Great Danes, Newfoundlands, Dobermans and Irish wolf-
hounds. In the Doberman pinscher, the disease is common and is
apparently inherited in an autosomal dominant manner (Meurs
et al., 2007). Heart remodelling is preceded by detectable modifica-
tions of muscular electroactivity (Wess et al., 2010). Using old
unaffected dogs as controls, a highly significant association with
dilated cardiomyopathy has been detected on chromosome 5 in
Dobermans (Mausberg et al., 2011).
Myxomatous mitral valve disease
Myxomatous mitral valve disease (MMVD) is another cardiac
condition that is very frequent in humans. This syndrome is char-
acterised by the enlargement of the mitral valve leading eventually
to its prolapse into the left atrium on ventricular contraction (mi-
tral regurgitation). The causes of MMVD in humans remain un-
known, but the disease is clustered in families. A similar disease
has a very high prevalence in Cavalier King Charles spaniels and
GWAS conducted with 100 cases and 100 controls have recently
identified two novel candidate regions. Studies are currently
underway to identify the causative gene and mutation within the
regions (Madsen et al., 2011).
Intervertebral disc disease
Another promising study pertains to intervertebral disc hernia-
tion. This condition commonly affects Dachshunds, with a contin-
uous spectrum of disc degeneration, suggesting a complex
aetiology. Disease severity can be quantified from the number of
calcified discs. Using 50 cases and 50 controls, a major locus signif-
icantly associated with the condition has been identified on chro-
mosome 12. The region is currently being re-sequenced to
identify variants and to study their involvement in the pathology
(Mogensen et al., 2011).
Idiopathic epilepsy
Several idiopathic epilepsies (IE) in the dog are being studied
and novel IE loci have been mapped to several different chromo-
somes for various breeds, including Belgian shepherds, Norwich
and Border terriers, the Schipperke and the Finnish Spitz. Sequence
capture and next-generation sequencing are currently being ap-
plied to screen the associated regions for mutations. The ongoing
studies indicate that most IEs in dogs are genetically complex
and require large cohorts and careful phenotyping to yield vali-
dated results. Interestingly, the newly mapped loci do not contain
any known epilepsy genes. This study may therefore lead to the
discovery of novel genes for common forms of human epilepsy.
Other studied diseases, including inflammatory disorders and
cancers, show either suggestive or significant associations to mul-
tiple loci and are currently undergoing additional research. In some
cohorts, the stratification that is sometimes present even within
canine breeds may impede the appearance of clear signals. Case-
control studies are usually designed so that only dogs that are
unrelated at the parental or grandparental level are included, but
this may not completely control the effect of the complex pedigree
structure in dogs. Cautious genetic design and analytical ap-
proaches that explicitly take account of the pedigree structure,
such as GenAbel (Aulchenko et al., 2007), EMMA-X (Kang et al.,
2008) and GCTA (Yang et al., 2011) are currently being exploited.
Copy number variation (CNV) in dogs
An additional initiative of the consortium has been to character-
ise the number and position of copy number variants (CNVs) in dog
breeds studied by LUPA. The study aimed to map CNVs in >50 dogs
from 17 breeds and three wolves by comparative genome hybrid-
isation (aCGH). A high-density Nimblegen array with 2.1 million
probes was used, giving a resolution of approximately 1 kb spacing
across the canine genome. Structural changes may underlie pheno-
typic variation, as extensively documented in domestic animals.
For instance, dominant white colour in pigs (Moller et al., 1996),
the hair ridge in Rhodesian Ridgeback dogs (Salmon Hillbertz
et al., 2007), greying with age in horses (Rosengren Pielberg
et al., 2008) and familial Shar-Pei fever (Olsson et al., 2011) are
all caused by duplications.
Preliminary analysis of the aCGH data has revealed thousands of
CNVs. Analyses are being conducted to assess the number of CNVs
shared between breeds or specific to a given breed, as well as to
identify the possible biological impact of CNVs based on gene con-
tent and biological pathways. The aCGH information aids in the
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interpretation of fluorescence intensities from SNP array data to
determine the CNV genotype of individual dogs and its possible
correlation with phenotype and/or disease status.
Detecting signatures of selection
The LUPA database, already containing genotypes from 10,000
dogs, can be used to perform GWAS across breeds, with the aim
to identify variants underlying traits shared by several breeds, as
has already been documented in other studies (Jones et al., 2008;
Cadieu et al., 2009; Akey et al., 2010; Bannasch et al., 2010; Boyko
et al., 2010). An alternative approach searches for selective sweeps:
regions with reduced heterozygosity associated with a specific trait
within a single or within a group of breeds that share the same trait
(A. Vaysse personal communication).
A recent LUPA collaborative effort (Olsson et al., 2011) has taken
advantage of this selective-sweep approach to identify the region
underlying the thickened and wrinkled skin of Chinese Shar-Pei
dogs. This approach was combined with a traditional GWAS to
identify the gene for familial Shar-Pei fever, a form of periodic fe-
ver. The region is located on chromosome 13 near the HAS2 gene,
a rate-limiting enzyme for the synthesis of hyaluronic acid (HA).
HA is a major constituent of mucin in the thickened skin typically
observed in Shar-Peis. Shar-Peis harbour a duplication 350 kb up-
stream of the HAS2 gene; a high copy number of this duplication
is associated with both increased HAS2 expression and the periodic
fever syndrome. These results call for studies exploring the role of
hyaluronan in human periodic fevers.
Conclusions
The 4-year European LUPA project has already fulfilled many of
its objectives, elucidating the molecular basis of four monogenic
diseases, including the discovery of novel genes shown to be in-
volved in the equivalent human pathologies. Canine tests have
been developed concomitantly to help reduce the frequency of
these diseases in the relevant breeds. LUPA has also improved ca-
nine genetics tools by designing a new highly efficient 172 K Illu-
mina array. Both the array and CNV characterisation help to
better mine disease susceptibility concealed in the canine genome.
Using these tools, LUPA partners have already identified loci
associated with susceptibility to several complex disorders. More
results should follow in the coming months and years. Fine-map-
ping of the associated genomic regions and high throughput
sequencing experiments to find the causative genes and mutations
are ongoing. Even if it may take some time to identify the actual
causative mutations and/or precise molecular mechanisms leading
to disease (especially when dealing with regulatory mutations),
identifying the causative genes or pathways, which is relatively
easier, may on its own pave the way for the investigation of similar
pathways in the corresponding human disorders (Wilbe et al.,
2010), as well as for the identification of novel drug targets. Per-
sonalised medicine for dogs, based on the genes and pathways
underlying the development of specific disorders, may be a future
possibility for veterinary medicine. We also envisage clinical trials
in dogs before translating them to humans, in order to test new
therapies for the benefit of both species.
A major achievement of LUPA is to have greatly improved the
dialogue between veterinary clinicians and geneticists throughout
Europe and the rest of the world. The benefit of collaborating and
building cohorts in a multicentric fashion has become obvious for
everyone involved in the project. This was quite difficult before
LUPA. The initiative has also been well received by breeders and
kennel clubs, whose collaboration is essential for improving detec-
tion of disease syndromes and for sample collection. Dog owners
and the general public have been far better informed, encouraging
them to contribute to ongoing and new studies. Human geneticists
and clinicians have shown increasing interest in the remarkable
genetic relevance of the dog to its masters.
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